Canada’s venture capital problem isn’t a funding gap—it’s a returns gap

Canada's venture capital challenge is not a funding shortage but a returns crisis that rational capital allocators are beginning to address through portfolio reallocation. The median Canadian venture fund has generated returns of 1.2x to 1.4x invested capital over a quarter-century, translating to approximately 10 percent annualized returns before tax according to data from the Canadian Venture Capital and Private Equity Association. This return profile becomes particularly stark when compared against public equity benchmarks: the S&P/TSX Composite delivered 9.7 percent returns over the same period while offering a 3 percent dividend yield, liquidity on demand, and a multiple of invested capital near 2.5x.

The severity of this performance gap has created a basic rational choice problem for institutional investors. Venture capital requires investors to accept total illiquidity, bear enormous risk, and wait a decade or longer before outcomes crystallize. In exchange, they receive returns that barely exceed—or trail—those available through passively indexed equity exposure with substantially lower risk and daily liquidity. The downstream evidence of this capital reallocation is unambiguous: venture capital investment as a share of Canadian GDP contracted from nearly 0.5 percent in 2021 to 0.2 percent in 2024, signaling a fundamental loss of investor confidence rather than temporary market conditions.

This returns deficit extends to cross-border comparisons. Canadian venture funds underperform U.S. counterparts by approximately 30 percent despite managing similar investment volumes, indicating that the problem is structural to Canadian fund management and portfolio company outcomes rather than deal availability. Additionally, Canadian VC funds operate at a scale disadvantage; a single large U.S. venture fund can deploy more capital than multiple Canadian funds combined, amplifying the competitive pressure on returns and fundraising capability.

The policy response—a $750 million government pledge to close perceived early-stage funding gaps—misidentifies the constraint. The issue is not that capital is unavailable for early-stage companies; it is that deployed capital fails to generate sufficient returns to justify the risk and illiquidity burden. Without addressing the underlying factors driving Canadian venture underperformance relative to U.S. and public equity alternatives, additional capital infusion is unlikely to reverse the structural shift in allocation decisions by sophisticated institutional investors.